Overweight and Obesity among Recipients of Antiretroviral Therapy at HIV Clinics in Gaborone, Botswana: Factors Associated with Change in Body Mass Index.

IF 1.1 Q4 INFECTIOUS DISEASES
AIDS Research and Treatment Pub Date : 2020-01-04 eCollection Date: 2020-01-01 DOI:10.1155/2020/8016791
Jose Gaby Tshikuka, Mgaywa Gilbert Mjungu Damas Magafu, Goabaone Rankgoane-Pono, Julius Chacha Mwita, Tiny Masupe, Shimeles Genna Hamda, Roy Tapera, Mooketsi Molefi, Joseph Tshibangu, John Thato Tlhakanelo
{"title":"Overweight and Obesity among Recipients of Antiretroviral Therapy at HIV Clinics in Gaborone, Botswana: Factors Associated with Change in Body Mass Index.","authors":"Jose Gaby Tshikuka,&nbsp;Mgaywa Gilbert Mjungu Damas Magafu,&nbsp;Goabaone Rankgoane-Pono,&nbsp;Julius Chacha Mwita,&nbsp;Tiny Masupe,&nbsp;Shimeles Genna Hamda,&nbsp;Roy Tapera,&nbsp;Mooketsi Molefi,&nbsp;Joseph Tshibangu,&nbsp;John Thato Tlhakanelo","doi":"10.1155/2020/8016791","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Factors associated with overweight/obesity among antiretroviral therapy (ART) recipients have not been sufficiently studied in Botswana.</p><p><strong>Objectives: </strong>To: (i) estimate the prevalence and trends in overweight/obesity by duration of exposure to ART among recipients, (ii) assess changes in BMI categories among ART recipients between their first clinic visit (BMI-1) and their last clinic visit (BMI-2), (iii) identify ART regimen that predicts overweight/obesity better than the others and factors associated with BMI changes among ART recipients.</p><p><strong>Methods: </strong>A 12-year retrospective record-based review was conducted. Potential predictors of BMI change among patients after at least three years of ART exposure were examined using a multiple logistic regression model. Adjusted odds ratios (AOR) and their 95% confidence intervals (CIs) were computed. ART regimens, duration of exposure to ART, and recipients' demographic and biomedical characteristics including the presence or absence of diabetes mellitus-related comorbidities (DRC), defined as any morbidity associated with type 2 diabetes as described in the international statistical classification of diseases and related health problems (ICD-10-CM) codebook index, were investigated as potential predictors of overweight/obesity.</p><p><strong>Results: </strong>Twenty-nine percent of recipients were overweight, 16.6% had obesity of whom 2.4% were morbidly-obese at the last clinic visit. Overweight/obese recipients were more likely to be female, to have DRC and less likely to have CD4 count between 201 and 249 cells/mm<sup>3</sup>. Neither the first-line nor the second-, third-line ART regimens predicted overweight/obesity better than the other and neither did the duration of exposure to ART. No significant linear trends were observed in the prevalence of overweight/obesity by the duration of exposure to ART.</p><p><strong>Conclusion: </strong>These results suggest that the ART regimens studied have a comparable effect on overweight/obesity and that the duration of exposure does not affect the outcome. This study calls for further research to elucidate the relative contribution of various factors to BMI change among recipients, including ART regimens.</p>","PeriodicalId":46303,"journal":{"name":"AIDS Research and Treatment","volume":"2020 ","pages":"8016791"},"PeriodicalIF":1.1000,"publicationDate":"2020-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/8016791","citationCount":"10","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"AIDS Research and Treatment","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2020/8016791","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 10

Abstract

Background: Factors associated with overweight/obesity among antiretroviral therapy (ART) recipients have not been sufficiently studied in Botswana.

Objectives: To: (i) estimate the prevalence and trends in overweight/obesity by duration of exposure to ART among recipients, (ii) assess changes in BMI categories among ART recipients between their first clinic visit (BMI-1) and their last clinic visit (BMI-2), (iii) identify ART regimen that predicts overweight/obesity better than the others and factors associated with BMI changes among ART recipients.

Methods: A 12-year retrospective record-based review was conducted. Potential predictors of BMI change among patients after at least three years of ART exposure were examined using a multiple logistic regression model. Adjusted odds ratios (AOR) and their 95% confidence intervals (CIs) were computed. ART regimens, duration of exposure to ART, and recipients' demographic and biomedical characteristics including the presence or absence of diabetes mellitus-related comorbidities (DRC), defined as any morbidity associated with type 2 diabetes as described in the international statistical classification of diseases and related health problems (ICD-10-CM) codebook index, were investigated as potential predictors of overweight/obesity.

Results: Twenty-nine percent of recipients were overweight, 16.6% had obesity of whom 2.4% were morbidly-obese at the last clinic visit. Overweight/obese recipients were more likely to be female, to have DRC and less likely to have CD4 count between 201 and 249 cells/mm3. Neither the first-line nor the second-, third-line ART regimens predicted overweight/obesity better than the other and neither did the duration of exposure to ART. No significant linear trends were observed in the prevalence of overweight/obesity by the duration of exposure to ART.

Conclusion: These results suggest that the ART regimens studied have a comparable effect on overweight/obesity and that the duration of exposure does not affect the outcome. This study calls for further research to elucidate the relative contribution of various factors to BMI change among recipients, including ART regimens.

Abstract Image

博茨瓦纳哈博罗内艾滋病诊所接受抗逆转录病毒治疗的患者中超重和肥胖:与体重指数变化相关的因素
背景:在博茨瓦纳,与抗逆转录病毒治疗(ART)接受者中超重/肥胖相关的因素尚未得到充分研究。目的:通过接受抗逆转录病毒治疗的持续时间来估计接受抗逆转录病毒治疗的人群中超重/肥胖的患病率和趋势,评估接受抗逆转录病毒治疗的人群在第一次门诊就诊(BMI-1)和最后一次门诊就诊(BMI-2)之间的BMI类别变化,确定比其他治疗方案更能预测超重/肥胖的抗逆转录病毒治疗方案,以及与接受抗逆转录病毒治疗人群中BMI变化相关的因素。方法:对12年的回顾性文献进行回顾性分析。使用多元逻辑回归模型对接受抗逆转录病毒治疗至少三年的患者BMI变化的潜在预测因素进行了检查。计算校正优势比(AOR)及其95%置信区间(CIs)。作为超重/肥胖的潜在预测因素,研究了抗逆转录病毒治疗方案、接受抗逆转录病毒治疗的持续时间以及接受者的人口统计学和生物医学特征,包括是否存在糖尿病相关合并症(DRC), DRC定义为国际疾病和相关健康问题统计分类(ICD-10-CM)代码本指数中描述的与2型糖尿病相关的任何发病率。结果:29%的受助人超重,16.6%的受助人肥胖,其中2.4%的受助人在最后一次就诊时为病态肥胖。超重/肥胖受体更有可能是女性,患有DRC, CD4细胞计数在201 - 249细胞/mm3之间的可能性较小。一线、二线、三线抗逆转录病毒治疗方案对超重/肥胖的预测都不优于其他方案,接受抗逆转录病毒治疗的持续时间也不优于其他方案。在接受抗逆转录病毒治疗的持续时间内,未观察到超重/肥胖患病率有显著的线性趋势。结论:这些结果表明,所研究的抗逆转录病毒治疗方案对超重/肥胖有相当的影响,并且暴露的持续时间不影响结果。这项研究需要进一步的研究来阐明各种因素对接受者BMI变化的相对贡献,包括ART方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
AIDS Research and Treatment
AIDS Research and Treatment INFECTIOUS DISEASES-
CiteScore
3.10
自引率
0.00%
发文量
13
审稿时长
18 weeks
期刊介绍: AIDS Research and Treatment is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies focused on all aspects of HIV and AIDS, from the molecular basis of disease to translational and clinical research. In addition, articles relating to prevention, education, and behavior change will be considered
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信